Evidence map›Paper›PMID 17874045›Full record

ArticleMedical molecular morphology2007

Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis.

Yoshiro Kai, Hiroyuki Yoneyama, Jun Koyama, Kaoru Hamada, Hiroshi Kimura, Kouji Matsushima

Abstract read
PubMed Publisher
In one paragraph

Article in Medical molecular morphology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. The Genetics behind Sulfation: Impact on Airway Remodeling.Journal of personalized medicine · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. A validated 3D microstructure-based constitutive model of coronary artery adventitia.Journal of applied physiology (Bethesda, Md. : 1985) · 2016
    Article
  9. Subepithelial Accumulation of Versican in a Cockroach Antigen-Induced Murine Model of Allergic Asthma.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2016
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. TGF-β: Titan of Lung Fibrogenesis.Current enzyme inhibition · 2010
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yoshiro KaiDepartment of Molecular Preventive Medicine and SORST, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
Hiroyuki Yoneyama
Jun Koyama
Kaoru Hamada
Hiroshi Kimura
Kouji Matsushima
Nara Medical University · JPStelic Institute (Japan) · JPThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary fibrosis is characterized by an accumulation of inflammatory cells in the lung interstitium, followed by an increased deposition of extracellular matrix. Macrophages play a vital role in this disease by mediating the progression from inflammation to fibrosis, but the mechanisms by which macrophages are retained at these sites are not fully understood. Although the transmigration of leukocytes is regulated by chemokines, glycosaminoglycans modulate the function of chemokines and the migration of leukocytes. Accordingly, we investigated the role of chondroitin sulfate proteoglycans (CSPGs) in a murine bleomycin-induced pulmonary fibrosis models. After intratracheal injection of bleomycin or saline, mice were randomized to receive one intravenous injection and continuous infusion of the CSPG-digesting enzyme chondroitinase ABC (ChABC), or vehicle, for 7 days. CSPGs were readily induced and progressively augmented after the bleomycin challenge. Although CSPGs inhibited the early CCL2-dependent recruitment of macrophages, deposited CSPGs retained macrophages in fibrotic interstitium in a CD44-dependent manner. Treatment with ChABC in vivo dramatically increased survival of the mice and reduced collagen deposition by inhibiting persistent macrophage accumulation. These results indicate a pivotal role for CSPGs in macrophage-mediated lung fibrogenesis and suggest a possible new therapeutic role for ChABC in pulmonary fibrosis.

Indexed as

AnimalsBleomycinBronchoalveolar Lavage FluidChemokine CCL2ChemotaxisChondroitin ABC LyaseChondroitin Sulfate ProteoglycansFemaleGene Expression RegulationHyaluronan ReceptorsKineticsMacrophagesMiceMice, Inbred C57BLModels, BiologicalPulmonary FibrosisBleomycinChemokine CCL2Chondroitin ABC LyaseChondroitin Sulfate ProteoglycansHyaluronan Receptors

Identifiers

PMID17874045
OpenAlexW2011882976

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.